nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Dizziness—Everolimus—kidney cancer	0.000498	0.000498	CcSEcCtD
Tobramycin—Abdominal pain—Sunitinib—kidney cancer	0.000498	0.000498	CcSEcCtD
Tobramycin—Body temperature increased—Sunitinib—kidney cancer	0.000498	0.000498	CcSEcCtD
Tobramycin—Diarrhoea—Erlotinib—kidney cancer	0.000498	0.000498	CcSEcCtD
Tobramycin—Nervous system disorder—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Tobramycin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000495	0.000495	CcSEcCtD
Tobramycin—Renal failure acute—Doxorubicin—kidney cancer	0.000493	0.000493	CcSEcCtD
Tobramycin—Feeling abnormal—Dactinomycin—kidney cancer	0.000491	0.000491	CcSEcCtD
Tobramycin—Skin disorder—Gemcitabine—kidney cancer	0.000491	0.000491	CcSEcCtD
Tobramycin—Rhinitis—Capecitabine—kidney cancer	0.00049	0.00049	CcSEcCtD
Tobramycin—Vision blurred—Paclitaxel—kidney cancer	0.000488	0.000488	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000487	0.000487	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000485	0.000485	CcSEcCtD
Tobramycin—Pharyngitis—Capecitabine—kidney cancer	0.000485	0.000485	CcSEcCtD
Tobramycin—Urinary tract disorder—Capecitabine—kidney cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Hypersensitivity—Sorafenib—kidney cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Anorexia—Gemcitabine—kidney cancer	0.000482	0.000482	CcSEcCtD
Tobramycin—Vomiting—Vinblastine—kidney cancer	0.000481	0.000481	CcSEcCtD
Tobramycin—Dizziness—Erlotinib—kidney cancer	0.000481	0.000481	CcSEcCtD
Tobramycin—Ill-defined disorder—Paclitaxel—kidney cancer	0.000481	0.000481	CcSEcCtD
Tobramycin—Connective tissue disorder—Capecitabine—kidney cancer	0.00048	0.00048	CcSEcCtD
Tobramycin—Vomiting—Everolimus—kidney cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Anaemia—Paclitaxel—kidney cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Urethral disorder—Capecitabine—kidney cancer	0.000479	0.000479	CcSEcCtD
Tobramycin—Renal impairment—Doxorubicin—kidney cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Paraesthesia—Vincristine—kidney cancer	0.000478	0.000478	CcSEcCtD
Tobramycin—Rash—Everolimus—kidney cancer	0.000475	0.000475	CcSEcCtD
Tobramycin—Dermatitis—Everolimus—kidney cancer	0.000475	0.000475	CcSEcCtD
Tobramycin—Headache—Vinblastine—kidney cancer	0.000474	0.000474	CcSEcCtD
Tobramycin—Angioedema—Paclitaxel—kidney cancer	0.000474	0.000474	CcSEcCtD
Tobramycin—Headache—Everolimus—kidney cancer	0.000472	0.000472	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—kidney cancer	0.000471	0.000471	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—kidney cancer	0.000471	0.000471	CcSEcCtD
Tobramycin—Visual impairment—Capecitabine—kidney cancer	0.000471	0.000471	CcSEcCtD
Tobramycin—Asthenia—Sorafenib—kidney cancer	0.000469	0.000469	CcSEcCtD
Tobramycin—Malaise—Paclitaxel—kidney cancer	0.000467	0.000467	CcSEcCtD
Tobramycin—Vertigo—Paclitaxel—kidney cancer	0.000466	0.000466	CcSEcCtD
Tobramycin—Lethargy—Doxorubicin—kidney cancer	0.000465	0.000465	CcSEcCtD
Tobramycin—Leukopenia—Paclitaxel—kidney cancer	0.000464	0.000464	CcSEcCtD
Tobramycin—Hypersensitivity—Sunitinib—kidney cancer	0.000464	0.000464	CcSEcCtD
Tobramycin—Decreased appetite—Vincristine—kidney cancer	0.000463	0.000463	CcSEcCtD
Tobramycin—Pruritus—Sorafenib—kidney cancer	0.000463	0.000463	CcSEcCtD
Tobramycin—Vomiting—Erlotinib—kidney cancer	0.000462	0.000462	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00046	0.00046	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Vincristine—kidney cancer	0.00046	0.00046	CcSEcCtD
Tobramycin—Rash—Erlotinib—kidney cancer	0.000459	0.000459	CcSEcCtD
Tobramycin—Dermatitis—Erlotinib—kidney cancer	0.000458	0.000458	CcSEcCtD
Tobramycin—Eye disorder—Capecitabine—kidney cancer	0.000457	0.000457	CcSEcCtD
Tobramycin—Headache—Erlotinib—kidney cancer	0.000456	0.000456	CcSEcCtD
Tobramycin—Tinnitus—Capecitabine—kidney cancer	0.000455	0.000455	CcSEcCtD
Tobramycin—Pain—Vincristine—kidney cancer	0.000455	0.000455	CcSEcCtD
Tobramycin—Paraesthesia—Gemcitabine—kidney cancer	0.000454	0.000454	CcSEcCtD
Tobramycin—Cough—Paclitaxel—kidney cancer	0.000452	0.000452	CcSEcCtD
Tobramycin—Asthenia—Sunitinib—kidney cancer	0.000452	0.000452	CcSEcCtD
Tobramycin—Dyspnoea—Gemcitabine—kidney cancer	0.00045	0.00045	CcSEcCtD
Tobramycin—Nausea—Vinblastine—kidney cancer	0.000449	0.000449	CcSEcCtD
Tobramycin—Nausea—Everolimus—kidney cancer	0.000448	0.000448	CcSEcCtD
Tobramycin—Diarrhoea—Sorafenib—kidney cancer	0.000448	0.000448	CcSEcCtD
Tobramycin—Pruritus—Sunitinib—kidney cancer	0.000445	0.000445	CcSEcCtD
Tobramycin—Angiopathy—Capecitabine—kidney cancer	0.000443	0.000443	CcSEcCtD
Tobramycin—Immune system disorder—Capecitabine—kidney cancer	0.000441	0.000441	CcSEcCtD
Tobramycin—Myalgia—Paclitaxel—kidney cancer	0.000441	0.000441	CcSEcCtD
Tobramycin—Chest pain—Paclitaxel—kidney cancer	0.000441	0.000441	CcSEcCtD
Tobramycin—Mediastinal disorder—Capecitabine—kidney cancer	0.00044	0.00044	CcSEcCtD
Tobramycin—Decreased appetite—Gemcitabine—kidney cancer	0.000439	0.000439	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—kidney cancer	0.000439	0.000439	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000438	0.000438	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000436	0.000436	CcSEcCtD
Tobramycin—Discomfort—Paclitaxel—kidney cancer	0.000436	0.000436	CcSEcCtD
Tobramycin—Gastrointestinal pain—Vincristine—kidney cancer	0.000435	0.000435	CcSEcCtD
Tobramycin—Dizziness—Sorafenib—kidney cancer	0.000433	0.000433	CcSEcCtD
Tobramycin—Pain—Gemcitabine—kidney cancer	0.000432	0.000432	CcSEcCtD
Tobramycin—Nausea—Erlotinib—kidney cancer	0.000432	0.000432	CcSEcCtD
Tobramycin—Diarrhoea—Sunitinib—kidney cancer	0.000431	0.000431	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—kidney cancer	0.000428	0.000428	CcSEcCtD
Tobramycin—Confusional state—Paclitaxel—kidney cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000426	0.000426	CcSEcCtD
Tobramycin—Erythema—Capecitabine—kidney cancer	0.000425	0.000425	CcSEcCtD
Tobramycin—Dehydration—Doxorubicin—kidney cancer	0.000423	0.000423	CcSEcCtD
Tobramycin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000423	0.000423	CcSEcCtD
Tobramycin—Abdominal pain—Vincristine—kidney cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Body temperature increased—Vincristine—kidney cancer	0.000421	0.000421	CcSEcCtD
Tobramycin—Dry skin—Doxorubicin—kidney cancer	0.000417	0.000417	CcSEcCtD
Tobramycin—Dysgeusia—Capecitabine—kidney cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Dizziness—Sunitinib—kidney cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Feeling abnormal—Gemcitabine—kidney cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Vomiting—Sorafenib—kidney cancer	0.000416	0.000416	CcSEcCtD
Tobramycin—Nervous system disorder—Paclitaxel—kidney cancer	0.000415	0.000415	CcSEcCtD
Tobramycin—Hypokalaemia—Doxorubicin—kidney cancer	0.000414	0.000414	CcSEcCtD
Tobramycin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000414	0.000414	CcSEcCtD
Tobramycin—Rash—Sorafenib—kidney cancer	0.000413	0.000413	CcSEcCtD
Tobramycin—Dermatitis—Sorafenib—kidney cancer	0.000412	0.000412	CcSEcCtD
Tobramycin—Back pain—Capecitabine—kidney cancer	0.000411	0.000411	CcSEcCtD
Tobramycin—Skin disorder—Paclitaxel—kidney cancer	0.000411	0.000411	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Headache—Sorafenib—kidney cancer	0.00041	0.00041	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—kidney cancer	0.000408	0.000408	CcSEcCtD
Tobramycin—Anorexia—Paclitaxel—kidney cancer	0.000403	0.000403	CcSEcCtD
Tobramycin—Muscular weakness—Doxorubicin—kidney cancer	0.000401	0.000401	CcSEcCtD
Tobramycin—Vision blurred—Capecitabine—kidney cancer	0.000401	0.000401	CcSEcCtD
Tobramycin—Vomiting—Sunitinib—kidney cancer	0.0004	0.0004	CcSEcCtD
Tobramycin—Body temperature increased—Gemcitabine—kidney cancer	0.000399	0.000399	CcSEcCtD
Tobramycin—Rash—Sunitinib—kidney cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Dermatitis—Sunitinib—kidney cancer	0.000397	0.000397	CcSEcCtD
Tobramycin—Ill-defined disorder—Capecitabine—kidney cancer	0.000395	0.000395	CcSEcCtD
Tobramycin—Headache—Sunitinib—kidney cancer	0.000394	0.000394	CcSEcCtD
Tobramycin—Asthma—Doxorubicin—kidney cancer	0.000393	0.000393	CcSEcCtD
Tobramycin—Anaemia—Capecitabine—kidney cancer	0.000393	0.000393	CcSEcCtD
Tobramycin—Hypersensitivity—Vincristine—kidney cancer	0.000392	0.000392	CcSEcCtD
Tobramycin—Eosinophilia—Doxorubicin—kidney cancer	0.00039	0.00039	CcSEcCtD
Tobramycin—Nausea—Sorafenib—kidney cancer	0.000389	0.000389	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000385	0.000385	CcSEcCtD
Tobramycin—Malaise—Capecitabine—kidney cancer	0.000384	0.000384	CcSEcCtD
Tobramycin—Vertigo—Capecitabine—kidney cancer	0.000382	0.000382	CcSEcCtD
Tobramycin—Asthenia—Vincristine—kidney cancer	0.000382	0.000382	CcSEcCtD
Tobramycin—Leukopenia—Capecitabine—kidney cancer	0.000381	0.000381	CcSEcCtD
Tobramycin—Paraesthesia—Paclitaxel—kidney cancer	0.00038	0.00038	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—kidney cancer	0.000379	0.000379	CcSEcCtD
Tobramycin—Bronchitis—Doxorubicin—kidney cancer	0.000378	0.000378	CcSEcCtD
Tobramycin—Dyspnoea—Paclitaxel—kidney cancer	0.000377	0.000377	CcSEcCtD
Tobramycin—Rash—Dactinomycin—kidney cancer	0.000376	0.000376	CcSEcCtD
Tobramycin—Nausea—Sunitinib—kidney cancer	0.000374	0.000374	CcSEcCtD
Tobramycin—Cough—Capecitabine—kidney cancer	0.000371	0.000371	CcSEcCtD
Tobramycin—Decreased appetite—Paclitaxel—kidney cancer	0.000368	0.000368	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000366	0.000366	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000365	0.000365	CcSEcCtD
Tobramycin—Diarrhoea—Vincristine—kidney cancer	0.000364	0.000364	CcSEcCtD
Tobramycin—Asthenia—Gemcitabine—kidney cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Chest pain—Capecitabine—kidney cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Myalgia—Capecitabine—kidney cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Pain—Paclitaxel—kidney cancer	0.000362	0.000362	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Tobramycin—Discomfort—Capecitabine—kidney cancer	0.000358	0.000358	CcSEcCtD
Tobramycin—Pruritus—Gemcitabine—kidney cancer	0.000357	0.000357	CcSEcCtD
Tobramycin—Weight decreased—Doxorubicin—kidney cancer	0.000356	0.000356	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—kidney cancer	0.000354	0.000354	CcSEcCtD
Tobramycin—Dizziness—Vincristine—kidney cancer	0.000352	0.000352	CcSEcCtD
Tobramycin—Infestation—Doxorubicin—kidney cancer	0.000351	0.000351	CcSEcCtD
Tobramycin—Infestation NOS—Doxorubicin—kidney cancer	0.000351	0.000351	CcSEcCtD
Tobramycin—Confusional state—Capecitabine—kidney cancer	0.00035	0.00035	CcSEcCtD
Tobramycin—Feeling abnormal—Paclitaxel—kidney cancer	0.000349	0.000349	CcSEcCtD
Tobramycin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000346	0.000346	CcSEcCtD
Tobramycin—Diarrhoea—Gemcitabine—kidney cancer	0.000346	0.000346	CcSEcCtD
Tobramycin—Renal failure—Doxorubicin—kidney cancer	0.000345	0.000345	CcSEcCtD
Tobramycin—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Tobramycin—Stomatitis—Doxorubicin—kidney cancer	0.000342	0.000342	CcSEcCtD
Tobramycin—Nervous system disorder—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Tobramycin—Thrombocytopenia—Capecitabine—kidney cancer	0.00034	0.00034	CcSEcCtD
Tobramycin—Vomiting—Vincristine—kidney cancer	0.000339	0.000339	CcSEcCtD
Tobramycin—Skin disorder—Capecitabine—kidney cancer	0.000337	0.000337	CcSEcCtD
Tobramycin—Urticaria—Paclitaxel—kidney cancer	0.000336	0.000336	CcSEcCtD
Tobramycin—Rash—Vincristine—kidney cancer	0.000336	0.000336	CcSEcCtD
Tobramycin—Dermatitis—Vincristine—kidney cancer	0.000335	0.000335	CcSEcCtD
Tobramycin—Body temperature increased—Paclitaxel—kidney cancer	0.000334	0.000334	CcSEcCtD
Tobramycin—Abdominal pain—Paclitaxel—kidney cancer	0.000334	0.000334	CcSEcCtD
Tobramycin—Headache—Vincristine—kidney cancer	0.000334	0.000334	CcSEcCtD
Tobramycin—Epistaxis—Doxorubicin—kidney cancer	0.000331	0.000331	CcSEcCtD
Tobramycin—Anorexia—Capecitabine—kidney cancer	0.000331	0.000331	CcSEcCtD
Tobramycin—Sinusitis—Doxorubicin—kidney cancer	0.000329	0.000329	CcSEcCtD
Tobramycin—Agranulocytosis—Doxorubicin—kidney cancer	0.000327	0.000327	CcSEcCtD
Tobramycin—Vomiting—Gemcitabine—kidney cancer	0.000321	0.000321	CcSEcCtD
Tobramycin—Rash—Gemcitabine—kidney cancer	0.000319	0.000319	CcSEcCtD
Tobramycin—Dermatitis—Gemcitabine—kidney cancer	0.000318	0.000318	CcSEcCtD
Tobramycin—Headache—Gemcitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Nausea—Vincristine—kidney cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Rhinitis—Doxorubicin—kidney cancer	0.000316	0.000316	CcSEcCtD
Tobramycin—Pharyngitis—Doxorubicin—kidney cancer	0.000313	0.000313	CcSEcCtD
Tobramycin—Paraesthesia—Capecitabine—kidney cancer	0.000312	0.000312	CcSEcCtD
Tobramycin—Hypersensitivity—Paclitaxel—kidney cancer	0.000312	0.000312	CcSEcCtD
Tobramycin—Urinary tract disorder—Doxorubicin—kidney cancer	0.000311	0.000311	CcSEcCtD
Tobramycin—Connective tissue disorder—Doxorubicin—kidney cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Dyspnoea—Capecitabine—kidney cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Urethral disorder—Doxorubicin—kidney cancer	0.000309	0.000309	CcSEcCtD
Tobramycin—Visual impairment—Doxorubicin—kidney cancer	0.000303	0.000303	CcSEcCtD
Tobramycin—Asthenia—Paclitaxel—kidney cancer	0.000303	0.000303	CcSEcCtD
Tobramycin—Decreased appetite—Capecitabine—kidney cancer	0.000302	0.000302	CcSEcCtD
Tobramycin—Nausea—Gemcitabine—kidney cancer	0.0003	0.0003	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.0003	0.0003	CcSEcCtD
Tobramycin—Pruritus—Paclitaxel—kidney cancer	0.000299	0.000299	CcSEcCtD
Tobramycin—Pain—Capecitabine—kidney cancer	0.000297	0.000297	CcSEcCtD
Tobramycin—Eye disorder—Doxorubicin—kidney cancer	0.000294	0.000294	CcSEcCtD
Tobramycin—Tinnitus—Doxorubicin—kidney cancer	0.000294	0.000294	CcSEcCtD
Tobramycin—Diarrhoea—Paclitaxel—kidney cancer	0.000289	0.000289	CcSEcCtD
Tobramycin—Feeling abnormal—Capecitabine—kidney cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Angiopathy—Doxorubicin—kidney cancer	0.000286	0.000286	CcSEcCtD
Tobramycin—Immune system disorder—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Tobramycin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000284	0.000284	CcSEcCtD
Tobramycin—Mediastinal disorder—Doxorubicin—kidney cancer	0.000284	0.000284	CcSEcCtD
Tobramycin—Dizziness—Paclitaxel—kidney cancer	0.00028	0.00028	CcSEcCtD
Tobramycin—Urticaria—Capecitabine—kidney cancer	0.000276	0.000276	CcSEcCtD
Tobramycin—Abdominal pain—Capecitabine—kidney cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Body temperature increased—Capecitabine—kidney cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Erythema—Doxorubicin—kidney cancer	0.000274	0.000274	CcSEcCtD
Tobramycin—Vomiting—Paclitaxel—kidney cancer	0.000269	0.000269	CcSEcCtD
Tobramycin—Dysgeusia—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Tobramycin—Rash—Paclitaxel—kidney cancer	0.000267	0.000267	CcSEcCtD
Tobramycin—Dermatitis—Paclitaxel—kidney cancer	0.000266	0.000266	CcSEcCtD
Tobramycin—Back pain—Doxorubicin—kidney cancer	0.000265	0.000265	CcSEcCtD
Tobramycin—Headache—Paclitaxel—kidney cancer	0.000265	0.000265	CcSEcCtD
Tobramycin—Vision blurred—Doxorubicin—kidney cancer	0.000258	0.000258	CcSEcCtD
Tobramycin—Hypersensitivity—Capecitabine—kidney cancer	0.000256	0.000256	CcSEcCtD
Tobramycin—Ill-defined disorder—Doxorubicin—kidney cancer	0.000254	0.000254	CcSEcCtD
Tobramycin—Anaemia—Doxorubicin—kidney cancer	0.000253	0.000253	CcSEcCtD
Tobramycin—Nausea—Paclitaxel—kidney cancer	0.000251	0.000251	CcSEcCtD
Tobramycin—Asthenia—Capecitabine—kidney cancer	0.000249	0.000249	CcSEcCtD
Tobramycin—Malaise—Doxorubicin—kidney cancer	0.000247	0.000247	CcSEcCtD
Tobramycin—Vertigo—Doxorubicin—kidney cancer	0.000246	0.000246	CcSEcCtD
Tobramycin—Pruritus—Capecitabine—kidney cancer	0.000246	0.000246	CcSEcCtD
Tobramycin—Leukopenia—Doxorubicin—kidney cancer	0.000245	0.000245	CcSEcCtD
Tobramycin—Cough—Doxorubicin—kidney cancer	0.000239	0.000239	CcSEcCtD
Tobramycin—Diarrhoea—Capecitabine—kidney cancer	0.000237	0.000237	CcSEcCtD
Tobramycin—Chest pain—Doxorubicin—kidney cancer	0.000233	0.000233	CcSEcCtD
Tobramycin—Myalgia—Doxorubicin—kidney cancer	0.000233	0.000233	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Tobramycin—Discomfort—Doxorubicin—kidney cancer	0.000231	0.000231	CcSEcCtD
Tobramycin—Dizziness—Capecitabine—kidney cancer	0.00023	0.00023	CcSEcCtD
Tobramycin—Confusional state—Doxorubicin—kidney cancer	0.000226	0.000226	CcSEcCtD
Tobramycin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000224	0.000224	CcSEcCtD
Tobramycin—Vomiting—Capecitabine—kidney cancer	0.000221	0.000221	CcSEcCtD
Tobramycin—Nervous system disorder—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Tobramycin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Tobramycin—Rash—Capecitabine—kidney cancer	0.000219	0.000219	CcSEcCtD
Tobramycin—Dermatitis—Capecitabine—kidney cancer	0.000219	0.000219	CcSEcCtD
Tobramycin—Headache—Capecitabine—kidney cancer	0.000217	0.000217	CcSEcCtD
Tobramycin—Skin disorder—Doxorubicin—kidney cancer	0.000217	0.000217	CcSEcCtD
Tobramycin—Anorexia—Doxorubicin—kidney cancer	0.000213	0.000213	CcSEcCtD
Tobramycin—Nausea—Capecitabine—kidney cancer	0.000206	0.000206	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000204	0.000204	CcSEcCtD
Tobramycin—Paraesthesia—Doxorubicin—kidney cancer	0.000201	0.000201	CcSEcCtD
Tobramycin—Dyspnoea—Doxorubicin—kidney cancer	0.000199	0.000199	CcSEcCtD
Tobramycin—Decreased appetite—Doxorubicin—kidney cancer	0.000194	0.000194	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000193	0.000193	CcSEcCtD
Tobramycin—Pain—Doxorubicin—kidney cancer	0.000191	0.000191	CcSEcCtD
Tobramycin—Feeling abnormal—Doxorubicin—kidney cancer	0.000184	0.000184	CcSEcCtD
Tobramycin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000183	0.000183	CcSEcCtD
Tobramycin—Urticaria—Doxorubicin—kidney cancer	0.000178	0.000178	CcSEcCtD
Tobramycin—Abdominal pain—Doxorubicin—kidney cancer	0.000177	0.000177	CcSEcCtD
Tobramycin—Body temperature increased—Doxorubicin—kidney cancer	0.000177	0.000177	CcSEcCtD
Tobramycin—Hypersensitivity—Doxorubicin—kidney cancer	0.000165	0.000165	CcSEcCtD
Tobramycin—Asthenia—Doxorubicin—kidney cancer	0.000161	0.000161	CcSEcCtD
Tobramycin—Pruritus—Doxorubicin—kidney cancer	0.000158	0.000158	CcSEcCtD
Tobramycin—Diarrhoea—Doxorubicin—kidney cancer	0.000153	0.000153	CcSEcCtD
Tobramycin—Dizziness—Doxorubicin—kidney cancer	0.000148	0.000148	CcSEcCtD
Tobramycin—Vomiting—Doxorubicin—kidney cancer	0.000142	0.000142	CcSEcCtD
Tobramycin—Rash—Doxorubicin—kidney cancer	0.000141	0.000141	CcSEcCtD
Tobramycin—Dermatitis—Doxorubicin—kidney cancer	0.000141	0.000141	CcSEcCtD
Tobramycin—Headache—Doxorubicin—kidney cancer	0.00014	0.00014	CcSEcCtD
Tobramycin—Nausea—Doxorubicin—kidney cancer	0.000133	0.000133	CcSEcCtD
